Top

Published in:

Open Access 28-03-2024 | Research

Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians

Authors: Cordula Gebel, Isabel Kruschel, Steffi Bodinger, Steffen T. Simon, Dennis A. Eichenauer, Anne Pralong, Ulrich Wedding

Published in: Annals of Hematology | Issue 5/2024

Abstract

Integrating palliative care into the treatment of patients with advanced hematological malignancies (HM) remains challenging. To explore treating physicians’ perspectives on current palliative care practice and to evaluate factors influencing integration, we conducted a nationwide online survey. Based on literature and expert review, the survey addressed the importance of palliative care, communication about life-threatening conditions, challenges in establishing goals of care, and factors influencing the integration of palliative care. 207 physicians treating patients with HM in Germany participated. We used standard descriptive statistics to analyze quantitative data and a content structuring approach. Most physicians considered palliative care in HM to be very important (60.6%) and discussed life-threatening conditions with more than half of their patients (52%), especially when goals of care were changed (87.0%) or when patients raised the topic (84.0%). Disease-related factors, different professional perspectives on prognosis, and patient hopes were the main barriers to changing goals of care, but collaboration with colleagues and multidisciplinary teams provided important support. Time constraints were identified as the main barrier to integrating palliative care. The majority worked well with palliative care teams. Referral processes and conditions were perceived as minor barriers. The study highlights the need to address barriers to integrating palliative care into the management of patients with advanced HM. Future research should aim at optimizing palliative care for patients with HM.

Available only for authorised users

Dunn S, Earp MA, Biondo P, Cheung WY, Kerba M, Tang PA et al (2021) Oncology clinicians’ challenges to providing Palliative Cancer Care—A theoretical domains Framework, Pan-cancer System Survey. Curr Oncol 28(2):1483–1494. https://doi.org/10.3390/curroncol28020140CrossRefPubMedPubMedCentral

Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al (2010) Early Palliative Care for patients with Metastatic non–small-cell Lung Cancer. N Engl J Med 363(8):733–742. https://doi.org/10.1056/NEJMoa1000678CrossRefPubMed

Haun MW, Estel S, Rücker G, Friederich HC, Villalobos M, Thomas M et al (2017) Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev 6(6):Cd011129. https://doi.org/10.1002/14651858.CD011129.pub2CrossRefPubMed

Kirtane K, Downey L, Lee SJ, Curtis JR, Engelberg RA (2018) Intensity of end-of-Life Care for patients with hematologic malignancies and the role of Race/Ethnicity. J Palliat Med 21(10):1466–1471. https://doi.org/10.1089/jpm.2018.0152CrossRefPubMedPubMedCentral

Egan PC, Belanger E, Panagiotou OA, Rao VB, Pelcovits A, LeBlanc TW et al (2020) Comparison of end-of-Life Care Quality outcomes and indicators of Palliative needs between Medicare Beneficiaries with solid and Hematologic Malignancies. Blood 136:11. https://doi.org/10.1182/blood-2020-143078CrossRef

El-Jawahri A, Nelson AM, Gray TF, Lee SJ, LeBlanc TW (2020) Palliative and End-of-life care for patients with hematologic malignancies. J Clin Oncol 38(9):944–953. https://doi.org/10.1200/jco.18.02386CrossRefPubMedPubMedCentral

Hui D, Kim SH, Kwon JH, Tanco KC, Zhang T, Kang JH et al (2012) Access to palliative care among patients treated at a comprehensive cancer center. Oncologist 17(12):1574–1580. https://doi.org/10.1634/theoncologist.2012-0192CrossRefPubMedPubMedCentral

Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR (2010) Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med 25(6):630–641. https://doi.org/10.1177/0269216310391692CrossRef

Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J et al (2014) Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 120(10):1572–1578. https://doi.org/10.1002/cncr.28614CrossRefPubMed

10.

Hui D, Bansal S, Park M, Reddy A, Cortes J, Fossella F et al (2015) Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists. Ann Oncol 26(7):1440–1446. https://doi.org/10.1093/annonc/mdv028CrossRefPubMedPubMedCentral

11.

Hochman MJ, Yu Y, Wolf SP, Samsa GP, Kamal AH, LeBlanc TW (2018) Comparing the Palliative Care needs of patients with hematologic and solid malignancies. J Pain Symptom Manage 55(1):82–8e1. https://doi.org/10.1016/j.jpainsymman.2017.08.030CrossRefPubMed

12.

Elliott E, Watson T, Singh D, Wong C, Lo SS (2021) Outcomes of Specialty Palliative Care interventions for patients with hematologic malignancies: a systematic review. J Pain Symptom Manag. https://doi.org/10.1016/j.jpainsymman.2021.03.014CrossRef

13.

Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E (2008) Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 11(3):422–427. https://doi.org/10.1089/jpm.2007.0184CrossRefPubMed

14.

Cheng WW, Willey J, Palmer JL, Zhang T, Bruera E (2005) Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med 8(5):1025–1032. https://doi.org/10.1089/jpm.2005.8.1025CrossRefPubMed

15.

LeBlanc TW, Roeland EJ, El-Jawahri A (2017) Early Palliative Care for patients with hematologic malignancies: is it really so difficult to achieve? Curr Hematol Malig Rep 12(4):300–308. https://doi.org/10.1007/s11899-017-0392-zCrossRefPubMed

16.

LeBlanc TW, O’Donnell JD, Crowley-Matoka M, Rabow MW, Smith CB, White DB et al (2015) Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract 11(2):e230–e8. https://doi.org/10.1200/JOP.2014.001859CrossRefPubMedPubMedCentral

17.

McCaughan D, Roman E, Smith AG, Garry AC, Johnson MJ, Patmore RD et al (2018) Palliative care specialists’ perceptions concerning referral of haematology patients to their services: findings from a qualitative study. BMC Palliat Care 17(1):33. https://doi.org/10.1186/s12904-018-0289-1CrossRefPubMedPubMedCentral

18.

Epstein AS, Goldberg GR, Meier DE (2012) Palliative care and hematologic oncology: the promise of collaboration. Blood Rev 26(6):233–239. https://doi.org/10.1016/j.blre.2012.07.001CrossRefPubMed

19.

Gebel C, Basten J, Kruschel I, Ernst T, Wedding U (2023) Knowledge, feelings, and willingness to use palliative care in cancer patients with hematologic malignancies and solid tumors: a prospective, cross-sectional study in a comprehensive cancer center in Germany. Support Care Cancer 31(7):445. https://doi.org/10.1007/s00520-023-07914-0CrossRefPubMedPubMedCentral

20.

Booker R, Dunn S, Earp MA, Sinnarajah A, Biondo PD, Simon JE (2020) Perspectives of hematology oncology clinicians about integrating palliative care in oncology. Curr Oncol 27(6):313–320. https://doi.org/10.3747/co.27.6305CrossRefPubMedPubMedCentral

21.

El-Jawahri A, LeBlanc TW, Burns LJ, Denzen E, Meyer C, Mau LW et al (2018) What do transplant physicians think about palliative care? A national survey study. Cancer 124(23):4556–4566. https://doi.org/10.1002/cncr.31709CrossRefPubMed

22.

Habib AR, Cronin AM, Earle CC, Tulsky JA, Mack JW, Abel GA et al (2019) How do blood Cancer doctors discuss prognosis? Findings from a National Survey of Hematologic oncologists. J Palliat Med 22(6):677–684. https://doi.org/10.1089/jpm.2018.0441CrossRefPubMedPubMedCentral

23.

Eysenbach G (2004) Improving the quality of web surveys: the Checklist for reporting results of internet E-Surveys (CHERRIES). J Med Internet Res 6(3):e34–e. https://doi.org/10.2196/jmir.6.3.e34CrossRefPubMedPubMedCentral

24.

Aldridge MD, Hasselaar J, Garralda E, van der Eerden M, Stevenson D, McKendrick K et al (2016) Education, implementation, and policy barriers to greater integration of palliative care: a literature review. Palliat Med 30(3):224–239. https://doi.org/10.1177/0269216315606645CrossRefPubMed

25.

Bennardi M, Diviani N, Gamondi C, Stüssi G, Saletti P, Cinesi I et al (2020) Palliative care utilization in oncology and hemato-oncology: a systematic review of cognitive barriers and facilitators from the perspective of healthcare professionals, adult patients, and their families. BMC Palliat Care 19(1):47. https://doi.org/10.1186/s12904-020-00556-7CrossRefPubMedPubMedCentral

26.

Bonares M, Le LW, Zimmermann C, Wentlandt K (2023) Specialist palliative care referral practices among oncologists, cardiologists, respirologists: a comparison of national survey studies. J Pain Symptom Manag. https://doi.org/10.1016/j.jpainsymman.2023.01.014CrossRef

27.

Earp MA, Sinnarajah A, Kerba M, Tang PA, Rodriguez-Arguello J, King S et al (2018) Opportunity is the greatest barrier to providing palliative care to advanced colorectal cancer patients: a survey of oncology clinicians. Curr Oncol 25(5):e480–e5. https://doi.org/10.3747/co.25.4021CrossRefPubMedPubMedCentral

28.

Santivasi WL, Childs DS, Wu KM, Partain DK, Litzow MR, LeBlanc TW et al (2021) Perceptions of Hematology among Palliative Care Physicians: results of a Nationwide Survey. J Pain Symptom Manag. https://doi.org/10.1016/j.jpainsymman.2021.04.021CrossRef

29.

Pralong A, Herling M, Holtick U, Scheid C, Hellmich M, Hallek M et al (2023) Developing a supportive and palliative care intervention for patients with allogeneic stem cell transplantation: protocol of a multicentre mixed-methods study (allo-PaS). BMJ Open 13(8):e066948. https://doi.org/10.1136/bmjopen-2022-066948CrossRefPubMedPubMedCentral

30.

Michie S, van Stralen MM, West R (2011) The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 6:42. https://doi.org/10.1186/1748-5908-6-42CrossRefPubMedPubMedCentral

31.

Kuckartz U (2018) Qualitative inhaltsanalyse. Methoden, Praxis, Computerunterstützung. Beltz - Beltz Juventa, Weinheim:

32.

Harnischfeger N, Rath HM, Alt-Epping B, Brand H, Haller K, Letsch A et al (2023) Association between oncologists’ death anxiety and their end-of-life communication with advanced cancer patients. Psycho-oncology 32(6):923–932. https://doi.org/10.1002/pon.6132CrossRefPubMed

33.

Baile WF, Lenzi R, Parker PA, Buckman R, Cohen L (2002) Oncologists’ attitudes toward and practices in giving Bad News: an exploratory study. J Clin Oncol 20(8):2189–2196. https://doi.org/10.1200/jco.2002.08.004CrossRefPubMed

34.

Brighton LJ, Bristowe K (2016) Communication in palliative care: talking about the end of life, before the end of life. Postgrad Med J 92(1090):466–470. https://doi.org/10.1136/postgradmedj-2015-133368CrossRefPubMed

35.

Gray TF, Temel JS, El-Jawahri A (2021) Illness and prognostic understanding in patients with hematologic malignancies. Blood Rev 45:100692. https://doi.org/10.1016/j.blre.2020.100692CrossRefPubMed

36.

Wedding U (2021) Palliative care of patients with haematological malignancies: strategies to overcome difficulties via integrated care. Lancet Healthy Longev. https://doi.org/10.1016/S2666-7568(21)00213-0CrossRefPubMed

37.

Shaulov A, Aviv A, Alcalde J, Zimmermann C (2022) Early integration of palliative care for patients with haematological malignancies. Br J Haematol 199(1):14–30. https://doi.org/10.1111/bjh.18286CrossRefPubMedPubMedCentral

38.

Prod’homme C, Touzet L, Pierrat M, Chevalier L, Lesaffre H, Berthon C et al (2021) Can palliative care consultation increase integration of palliative care for patients with hematologic malignancies? Blood Adv 5(8):2123–2127. https://doi.org/10.1182/bloodadvances.2021004369CrossRefPubMedPubMedCentral

39.

Anderson TM, Farrell MM, Moss G, Gupta M, Mooney S, Daunov K et al (2022) The perspectives of oncology healthcare providers on the role of palliative care in a comprehensive cancer center. BMC Palliat Care 21(1):148. https://doi.org/10.1186/s12904-022-01039-7CrossRefPubMedPubMedCentral

40.

Dowling M, Fahy P, Houghton C, Smalle M (2020) A qualitative evidence synthesis of healthcare professionals’ experiences and views of palliative care for patients with a haematological malignancy. Eur J Cancer Care (Engl) 29(6). https://doi.org/10.1111/ecc.13316

41.

Fenton JJ, Duberstein PR, Kravitz RL, Xing G, Tancredi DJ, Fiscella K et al (2018) Impact of prognostic discussions on the patient-physician relationship: prospective cohort study. J Clin Oncol 36(3):225–230. https://doi.org/10.1200/jco.2017.75.6288CrossRefPubMed

42.

Gidwani R, Nevedal A, Patel M, Blayney DW, Timko C, Ramchandran K et al (2017) The appropriate provision of primary versus specialist Palliative Care to Cancer patients: oncologists’ perspectives. J Palliat Med 20(4):395–403. https://doi.org/10.1089/jpm.2016.0399CrossRefPubMed

43.

McDarby M, Carpenter BD (2019) Barriers and facilitators to effective Inpatient Palliative Care consultations: a qualitative analysis of interviews with Palliative Care and Nonpalliative Care Providers. Am J Hospice Palliat Medicine® 36(3):191–199. https://doi.org/10.1177/1049909118793635CrossRef

44.

Hui D, Bruera E (2016) Integrating palliative care into the trajectory of cancer care. Nat Reviews Clin Oncol 13(3):159–171. https://doi.org/10.1038/nrclinonc.2015.201CrossRef

45.

Mo L, Urbauer DL, Bruera E, Hui D (2020) Recommendations for Palliative and Hospice Care in NCCN guidelines for treatment of Cancer. Oncologist 26(1):77–83. https://doi.org/10.1002/onco.13515CrossRefPubMedPubMedCentral

46.

Hui D, Heung Y, Bruera E (2022) Timely Palliative Care: personalizing the process of Referral. Cancers (Basel) 14(4). https://doi.org/10.3390/cancers14041047

47.

Wei RL, Mattes MD, Yu J, Thrasher A, Shu HK, Paganetti H et al (2017) Attitudes of radiation oncologists toward palliative and supportive care in the United States: Report on national membership survey by the American Society for Radiation Oncology (ASTRO). Pract Radiat Oncol 7(2):113–119. https://doi.org/10.1016/j.prro.2016.08.017CrossRefPubMed

48.

Roch C, van Oorschot B (2020) Screening auf Palliativbedarf Bei stationären Krebspatienten. Der Onkologe 26(8):752–757. https://doi.org/10.1007/s00761-020-00791-wCrossRef

49.

ElMokhallalati Y, Bradley SH, Chapman E, Ziegler L, Murtagh FE, Johnson MJ et al (2020) Identification of patients with potential palliative care needs: a systematic review of screening tools in primary care. Palliat Med 34(8):989–1005. https://doi.org/10.1177/0269216320929552CrossRefPubMedPubMedCentral

50.

Odejide OO, Cronin AM, Earle CC, Tulsky JA, Abel GA (2017) Why are patients with blood cancers more likely to die without hospice? Cancer 123(17):3377–3384. https://doi.org/10.1002/cncr.30735CrossRefPubMed

51.

Cripe JC, Mills KA, Kuroki LK, Wan L, Hagemann AR, Fuh KC et al (2019) Gynecologic oncologists’ perceptions of Palliative Care and Associated barriers: a Survey of the Society of Gynecologic Oncology. Gynecol Obstet Invest 84(1):50–55. https://doi.org/10.1159/000491089CrossRefPubMed

52.

Ufere NN, Donlan J, Waldman L, Patel A, Dienstag JL, Friedman LS et al (2019) Physicians’ perspectives on Palliative Care for patients with end-stage liver disease: a National Survey Study. Liver Transpl 25(6):859–869. https://doi.org/10.1002/lt.25469CrossRefPubMedPubMedCentral

53.

Stichling K, Krause M, Ditscheid B, Hach M, Jansky M, Kaufmann M et al (2020) Factors influencing GPs’ perception of specialised palliative homecare (SPHC) importance – results of a cross-sectional study. BMC Palliat Care 19(1):117. https://doi.org/10.1186/s12904-020-00603-3CrossRefPubMedPubMedCentral

54.

El-Jawahri A, Meyer C, Mau L-W, Mattila D, Burns LJ, Ullrich C et al (2021) What do patients think about Palliative Care? A National Survey of hematopoietic stem cell transplant recipients. Blood 138:2968. https://doi.org/10.1182/blood-2021-149766CrossRef

Title: Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians
Authors: Cordula Gebel
Isabel Kruschel
Steffi Bodinger
Steffen T. Simon
Dennis A. Eichenauer
Anne Pralong
Ulrich Wedding
Publication date: 28-03-2024
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 5/2024
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-024-05726-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2024

Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection

Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report

Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape

How to improve RCHOP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of 21 randomized controlled trials

Posttransplant cyclophosphamide beyond haploidentical transplantation

Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials